Gunther disease: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
[[File:Congenital-erythropoietic-porphyria-1.jpg|Congenital | {{SI}} | ||
{{Infobox medical condition | |||
| name = Gunther disease | |||
| image = [[File:Congenital-erythropoietic-porphyria-1.jpg|alt=Congenital erythropoietic porphyria]] | |||
| caption = Skin lesions in congenital erythropoietic porphyria | |||
| synonyms = Congenital erythropoietic porphyria (CEP) | |||
| pronounce = | |||
| specialty = [[Hematology]] | |||
| symptoms = Photosensitivity, hemolytic anemia, red urine | |||
| onset = Birth or early infancy | |||
| duration = Lifelong | |||
| causes = Genetic mutation in the [[UROS]] gene | |||
| risks = | |||
| diagnosis = [[Urine test]], [[genetic testing]] | |||
| differential = [[Erythropoietic protoporphyria]], [[Porphyria cutanea tarda]] | |||
| prevention = Avoidance of sunlight | |||
| treatment = [[Blood transfusion]], [[bone marrow transplant]] | |||
| medication = | |||
| prognosis = Variable, can be severe | |||
| frequency = Rare | |||
| deaths = | |||
}} | |||
'''Gunther disease''', also known as '''congenital erythropoietic porphyria''' (CEP), is a rare [[autosomal recessive]] [[metabolic disorder]] that affects the [[heme]] biosynthesis pathway. It is characterized by a deficiency in the enzyme [[uroporphyrinogen III synthase]] (UROS), leading to the accumulation of [[porphyrins]] in the body. | |||
==Signs and Symptoms== | ==Signs and Symptoms== | ||
Individuals with Gunther disease typically present with severe [[photosensitivity]], leading to blistering and scarring of the skin upon exposure to sunlight. Other symptoms may include: | Individuals with Gunther disease typically present with severe [[photosensitivity]], leading to blistering and scarring of the skin upon exposure to sunlight. Other symptoms may include: | ||
| Line 8: | Line 29: | ||
* [[Erythrodontia]] (red discoloration of the teeth) | * [[Erythrodontia]] (red discoloration of the teeth) | ||
* [[Bone fragility]] | * [[Bone fragility]] | ||
==Pathophysiology== | ==Pathophysiology== | ||
Gunther disease is caused by mutations in the [[UROS]] gene, which encodes the enzyme uroporphyrinogen III synthase. This enzyme is crucial for the conversion of [[hydroxymethylbilane]] to [[uroporphyrinogen III]], a precursor in the heme biosynthesis pathway. Deficiency in UROS leads to the accumulation of non-physiological porphyrins, which are photosensitizing and cause cellular damage upon exposure to light. | Gunther disease is caused by mutations in the [[UROS]] gene, which encodes the enzyme uroporphyrinogen III synthase. This enzyme is crucial for the conversion of [[hydroxymethylbilane]] to [[uroporphyrinogen III]], a precursor in the heme biosynthesis pathway. Deficiency in UROS leads to the accumulation of non-physiological porphyrins, which are photosensitizing and cause cellular damage upon exposure to light. | ||
==Diagnosis== | ==Diagnosis== | ||
Diagnosis of Gunther disease is based on clinical presentation, family history, and laboratory tests. Key diagnostic tests include: | Diagnosis of Gunther disease is based on clinical presentation, family history, and laboratory tests. Key diagnostic tests include: | ||
| Line 17: | Line 36: | ||
* Genetic testing for mutations in the [[UROS]] gene | * Genetic testing for mutations in the [[UROS]] gene | ||
* Bone marrow examination to assess erythropoiesis | * Bone marrow examination to assess erythropoiesis | ||
==Treatment== | ==Treatment== | ||
There is no cure for Gunther disease, and treatment is primarily supportive. Management strategies include: | There is no cure for Gunther disease, and treatment is primarily supportive. Management strategies include: | ||
| Line 24: | Line 42: | ||
* [[Splenectomy]] in cases of severe splenomegaly | * [[Splenectomy]] in cases of severe splenomegaly | ||
* Bone marrow transplantation in severe cases | * Bone marrow transplantation in severe cases | ||
==Prognosis== | ==Prognosis== | ||
The prognosis for individuals with Gunther disease varies depending on the severity of the condition. Early diagnosis and management can improve the quality of life and reduce complications. | The prognosis for individuals with Gunther disease varies depending on the severity of the condition. Early diagnosis and management can improve the quality of life and reduce complications. | ||
==See also== | |||
== | |||
* [[Porphyria]] | * [[Porphyria]] | ||
* [[Heme]] | * [[Heme]] | ||
| Line 36: | Line 52: | ||
* [[Hemolytic anemia]] | * [[Hemolytic anemia]] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Metabolic disorders]] | [[Category:Metabolic disorders]] | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
[[Category:Skin conditions resulting from errors in metabolism]] | [[Category:Skin conditions resulting from errors in metabolism]] | ||
{{Medicine-stub}} | {{Medicine-stub}} | ||
Latest revision as of 02:18, 7 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Gunther disease | |
|---|---|
| |
| Synonyms | Congenital erythropoietic porphyria (CEP) |
| Pronounce | |
| Specialty | Hematology |
| Symptoms | Photosensitivity, hemolytic anemia, red urine |
| Complications | N/A |
| Onset | Birth or early infancy |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation in the UROS gene |
| Risks | |
| Diagnosis | Urine test, genetic testing |
| Differential diagnosis | Erythropoietic protoporphyria, Porphyria cutanea tarda |
| Prevention | Avoidance of sunlight |
| Treatment | Blood transfusion, bone marrow transplant |
| Medication | |
| Prognosis | Variable, can be severe |
| Frequency | Rare |
| Deaths | |
Gunther disease, also known as congenital erythropoietic porphyria (CEP), is a rare autosomal recessive metabolic disorder that affects the heme biosynthesis pathway. It is characterized by a deficiency in the enzyme uroporphyrinogen III synthase (UROS), leading to the accumulation of porphyrins in the body.
Signs and Symptoms[edit]
Individuals with Gunther disease typically present with severe photosensitivity, leading to blistering and scarring of the skin upon exposure to sunlight. Other symptoms may include:
- Hemolytic anemia
- Splenomegaly
- Hypertrichosis
- Erythrodontia (red discoloration of the teeth)
- Bone fragility
Pathophysiology[edit]
Gunther disease is caused by mutations in the UROS gene, which encodes the enzyme uroporphyrinogen III synthase. This enzyme is crucial for the conversion of hydroxymethylbilane to uroporphyrinogen III, a precursor in the heme biosynthesis pathway. Deficiency in UROS leads to the accumulation of non-physiological porphyrins, which are photosensitizing and cause cellular damage upon exposure to light.
Diagnosis[edit]
Diagnosis of Gunther disease is based on clinical presentation, family history, and laboratory tests. Key diagnostic tests include:
- Measurement of porphyrin levels in blood, urine, and feces
- Genetic testing for mutations in the UROS gene
- Bone marrow examination to assess erythropoiesis
Treatment[edit]
There is no cure for Gunther disease, and treatment is primarily supportive. Management strategies include:
- Avoidance of sunlight and use of protective clothing and sunscreen
- Blood transfusions to manage anemia
- Splenectomy in cases of severe splenomegaly
- Bone marrow transplantation in severe cases
Prognosis[edit]
The prognosis for individuals with Gunther disease varies depending on the severity of the condition. Early diagnosis and management can improve the quality of life and reduce complications.
See also[edit]
